ERBB2 and neoplasm: Recent studies have shown that treatment of MMTV-Neu transgenic mice with FK506 inhibited tumor growth, an effect that was ascribed to impaired NFAT4-dependent tumor angiogenesis.29 Our results suggest that part of the antitumorigenic effects of FK506 in this model also likely resulted from the inhibition of Cn in the tumor cells themselves.